Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Cell Therapy Market: By Cell Type, Non-Stem Cell Therapy), By Therapy Type, By Indication and Geography
Cell Therapy Market: By Cell Type, Non-Stem Cell Therapy), By Therapy Type, By Indication and Geography
Cell Therapy Market size was valued at US$ 8.22 billion in 2023 and is poised to grow at a significant CAGR of 13.3 % from 2024-2030. Rising the number of medical research facilities and clinical trial centers for the development of effective and novel medical solutions for patients as early as possible to diagnosis and treatment of chronic diseases such as cancer, cardiac abnormalities, and others. Furthermore, new innovations, technological advancement in the medical sector, and rising government initiatives for enhancing better advanced medical facilities will propel the market growth.
However, the high cost of research and low success rate are some of the factors expected to hinder market growth. Cell therapy is the use of transplanted human cells to replace or treat diseased tissue and/or cells. With the use of cutting-edge technologies, innovative products, and limitless imagination, a variety of distinct cell types may be utilized as part of a therapy or treatment for a range of diseases and disorders. In order to achieve a therapeutic outcome, it is a type of treatment in which a patient receives living cells via injection, grafting, or implant.
Study Period
2024-2030Base Year
2023CAGR
13.3%Largest Market
North AmericaFastest Growing Market
North America
Changing in the lifestyle and food habits rising in numerous of chronic diseases such as cancer, cardiovascular disease, neurodegenerative disorder and others thus increasing in the demand of huge number of advanced medical facilities which provide highly advanced treatment. Scientists are continuously researching and developing high-performance novel drug solutions thus to provide conventional diagnosis and treatment to the patients. Increasing government emphasis on clinical trials and cell therapy doses to develop the healthcare infrastructure. Moreover, rising disposable income, technological advancement and rising popularity of cell therapy will fuel the market growth during the forecast period.
North America accounted for larger revenue share in global cell therapy market with considerable CAGR. The growth in this region, especially in USA and Canada can be attributed to rising in the medical center and cost effective treatment. For instance, government of Canada has initiated Strategic Innovation Fund Program that invests in research activities carried out for stem cell therapies permitting development in stem cell therapy. European market dominates by advanced healthcare facility systems. European region is expected to dominate the market growth due to economically developed countries such as Germany, UK and France. In Asia Pacific cell therapy market is largely driven by the developing healthcare infrastructure, and skilled professionals, increase in disposable incomes.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 8.22 billion |
|
Market CAGR |
13.3% |
|
By Cell Type |
|
|
By Therapy Type |
|
|
By Indication |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The global cell therapy market size was valued at US$ 8.22 billion in 2023 and is projected to grow at a CAGR of 13.3% from 2024-2030.
ReproCELL, Prima BioMed, Q Therapeutics, Tessa Therapeutics, Sangamo BioSciences, VistaGen Therapeutics
North America is the fastest-growing region for cell therapy market
| 1. Executive Summary |
| 2. Global Cell Therapy Market Introduction |
| 2.1. Global Cell Therapy Market Taxonomy |
| 2.2. Global Cell Therapy Market Definitions |
| 2.2.1. By Cell Type |
| 2.2.2. By Therapy Type |
| 2.2.3. By Indication |
| 2.2.4. By Region |
| 3. Global Cell Therapy Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Current Trends |
| 3.5. Global Cell Therapy Market Dynamic Factors - Impact Analysis |
| 3.6. Mergers, Acquisitions, and Collaborations |
| 4. Global Cell Therapy Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Cell Therapy Market, By Cell Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1. Stem Cell Therapy |
| 5.1.1. Bone Marrow |
| 5.1.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.1.3. Market Opportunity Analysis |
| 5.1.2. Blood |
| 5.1.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.2.3. Market Opportunity Analysis |
| 5.1.3. Umbilical Cord-Derived |
| 5.1.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3.3. Market Opportunity Analysis |
| 5.1.4. Adipose-Derived Stem Cell |
| 5.1.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.4.3. Market Opportunity Analysis |
| 5.1.5. Others |
| 5.1.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.5.3. Market Opportunity Analysis |
| 5.2. Non-Stem Cell Therapy |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6. Global Cell Therapy Market, By Therapy Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.1. Allogenic Therapies |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Autologous Therapies |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7. Global Cell Therapy Market, By Indication, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.1. Malignancies |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Musculoskeletal Disorders |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Autoimmune Disorders |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Dermatology |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. Global Cell Therapy Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Latin America |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. MEA |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Global Cell Therapy Market - Opportunity Analysis Index, By Cell Type, Therapy Type, Indication, and Country, 2024 - 2030 |
| 9. North America Cell Therapy Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.1. Cell Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Stem Cell Therapy |
| 9.1.1.1. Bone Marrow |
| 9.1.1.2. Blood |
| 9.1.1.3. Umbilical Cord-Derived |
| 9.1.1.4. Adipose-Derived Stem Cell |
| 9.1.1.5. Others |
| 9.1.2. Non-Stem Cell Therapy |
| 9.2. Therapy Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1. Allogenic Therapies |
| 9.2.2. Autologous Therapies |
| 9.3. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1. Malignancies |
| 9.3.2. Musculoskeletal Disorders |
| 9.3.3. Autoimmune Disorders |
| 9.3.4. Dermatology |
| 9.3.5. Others |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1. United States |
| 9.4.2. Canada |
| 9.5. North America Cell Therapy Market - Opportunity Analysis Index, By Cell Type, Therapy Type, Indication, 2016-2027 |
| 9.6. North America Cell Therapy Market Dynamics Trends |
| 10. Europe Cell Therapy Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 10.1. Cell Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Stem Cell Therapy |
| 10.1.1.1. Bone Marrow |
| 10.1.1.2. Blood |
| 10.1.1.3. Umbilical Cord-Derived |
| 10.1.1.4. Adipose-Derived Stem Cell |
| 10.1.1.5. Others |
| 10.1.2. Non-Stem Cell Therapy |
| 10.2. Therapy Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Allogenic Therapies |
| 10.2.2. Autologous Therapies |
| 10.3. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1. Malignancies |
| 10.3.2. Musculoskeletal Disorders |
| 10.3.3. Autoimmune Disorders |
| 10.3.4. Dermatology |
| 10.3.5. Others |
| 10.4. Country Level Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1. UK |
| 10.4.2. Germany |
| 10.4.3. France |
| 10.4.4. Italy |
| 10.4.5. Spain |
| 10.4.6. Rest of Europe |
| 10.5. Europe Cell Therapy Market - Opportunity Analysis Index, By Cell Type, Therapy Type, Indication, 2016-2027 |
| 10.6. Europe Cell Therapy Market Dynamics Trends |
| 11. Asia Pacific Cell Therapy Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 11.1. Cell Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Stem Cell Therapy |
| 11.1.1.1. Bone Marrow |
| 11.1.1.2. Blood |
| 11.1.1.3. Umbilical Cord-Derived |
| 11.1.1.4. Adipose-Derived Stem Cell |
| 11.1.1.5. Others |
| 11.1.2. Non-Stem Cell Therapy |
| 11.2. Therapy Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Allogenic Therapies |
| 11.2.2. Autologous Therapies |
| 11.3. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1. Malignancies |
| 11.3.2. Musculoskeletal Disorders |
| 11.3.3. Autoimmune Disorders |
| 11.3.4. Dermatology |
| 11.3.5. Others |
| 11.4. Country Level Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1. China |
| 11.4.2. India |
| 11.4.3. ANZ |
| 11.4.4. Japan |
| 11.4.5. Rest of APAC |
| 11.5. Asia Pacific Cell Therapy Market - Opportunity Analysis Index, By Cell Type, Therapy Type, Indication, 2016-2027 |
| 11.6. Asia Pacific Cell Therapy Market Dynamics Trends |
| 12. MEA Cell Therapy Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 12.1. Cell Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Stem Cell Therapy |
| 12.1.1.1. Bone Marrow |
| 12.1.1.2. Blood |
| 12.1.1.3. Umbilical Cord-Derived |
| 12.1.1.4. Adipose-Derived Stem Cell |
| 12.1.1.5. Others |
| 12.1.2. Non-Stem Cell Therapy |
| 12.2. Therapy Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Allogenic Therapies |
| 12.2.2. Autologous Therapies |
| 12.3. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1. Malignancies |
| 12.3.2. Musculoskeletal Disorders |
| 12.3.3. Autoimmune Disorders |
| 12.3.4. Dermatology |
| 12.3.5. Others |
| 12.4. Country Level Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1. GCC Countries |
| 12.4.2. South Africa |
| 12.4.3. Rest of MEA |
| 12.5. MEA Cell Therapy Market - Opportunity Analysis Index, By Cell Type, Therapy Type, Indication, 2016-2027 |
| 12.6. MEA Cell Therapy Market Dynamics Trends |
| 13. Latin America Cell Therapy Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 13.1. Cell Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Stem Cell Therapy |
| 13.1.1.1. Bone Marrow |
| 13.1.1.2. Blood |
| 13.1.1.3. Umbilical Cord-Derived |
| 13.1.1.4. Adipose-Derived Stem Cell |
| 13.1.1.5. Others |
| 13.1.2. Non-Stem Cell Therapy |
| 13.2. Therapy Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1. Allogenic Therapies |
| 13.2.2. Autologous Therapies |
| 13.3. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1. Malignancies |
| 13.3.2. Musculoskeletal Disorders |
| 13.3.3. Autoimmune Disorders |
| 13.3.4. Dermatology |
| 13.3.5. Others |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1. Brazil |
| 13.4.2. Mexico |
| 13.4.3. Argentina |
| 13.4.4. Rest of LA |
| 13.5. Latin America Cell Therapy Market - Opportunity Analysis Index, By Cell Type, Therapy Type, Indication, 2016-2027 |
| 13.6. Latin America Cell Therapy Market Dynamics Trends |
| 14. Competition Landscape |
| 14.1. Strategic Dashboard of Top Market Players |
| 14.2. Company Profiles (Introduction, Financial Analysis, Product Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 14.2.1. Anterogen Co., Ltd. |
| 14.2.2. Capricor Therapeutics |
| 14.2.3. Celgene Corporation |
| 14.2.4. PHARMICELL Co., Ltd |
| 14.2.5. JCR Pharmaceuticals Co., Ltd. |
| 14.2.6. NuVasive, Inc. |
| 14.2.7. Kolon TissueGene, Inc. |
| 14.2.8. Osiris Therapeutics, Inc. |
| 14.2.9. Castle Creek Biosciences, Inc. |
| 14.2.10. Vericel Corporation |
| 14.2.11. Prima BioMed |
| 14.2.12. Q Therapeutics |
| 14.2.13. Tessa Therapeutics |
| 14.2.14. Sangamo BioSciences |
| 14.2.15. VistaGen Therapeutics |
| 14.2.16. Shire Regenerative Medicine |
| 14.2.17. Bellicum Pharmaceuticals |
| 14.2.18. Antibe Therapeutics |
| 14.2.19. BrainStorm Cell Therapeutics |
| 14.2.20. Fate Therapeutics |
| 14.2.21. Cytori Therapeutics |
| 14.2.22. Immunocellular Therapeutics |
| 15. Research Methodology |
| 16. Key Assumptions and Acronyms |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.